Kristen Raffensperger Selected Research

Proto-Oncogene Proteins c-met

1/2015	Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [99mTc] (AH-113018) or Cy 5** (AH-112543) Labeled Peptide.
10/2012	Immuno-PET of the hepatocyte growth factor receptor Met using the 1-armed antibody onartuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristen Raffensperger Research Topics

Disease

2	Neoplasms (Cancer) 01/2015 - 10/2012
1	Necrosis 01/2015

Drug/Important Bio-Agent (IBA)

2	Proto-Oncogene Proteins c-metIBA 01/2015 - 10/2012
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	cyanine dye 5IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 01/2015